$NVRO
NEVRO CORP

2023 Q3 Form 10-Q Financial Statement

#000095017023036543 Filed on August 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $103.9M $108.8M
YoY Change 3.38% 4.41%
Cost Of Revenue $34.35M $34.37M
YoY Change 10.21% 9.17%
Gross Profit $69.52M $74.44M
YoY Change 0.31% 2.35%
Gross Profit Margin 66.93% 68.42%
Selling, General & Admin $81.15M $86.76M
YoY Change 3.79% 3.32%
% of Gross Profit 116.74% 116.55%
Research & Development $13.92M $13.32M
YoY Change -0.76% 6.12%
% of Gross Profit 20.03% 17.89%
Depreciation & Amortization $1.723M $1.671M
YoY Change 7.55% 7.05%
% of Gross Profit 2.48% 2.24%
Operating Expenses $95.08M $100.1M
YoY Change -843.94% 3.69%
Operating Profit -$25.56M -$25.64M
YoY Change -131.14% 7.77%
Interest Expense $1.618M $1.730M
YoY Change 0.62% 7.59%
% of Operating Profit
Other Income/Expense, Net $234.0K -$338.0K
YoY Change -40.15% -191.85%
Pretax Income -$23.35M -$24.25M
YoY Change -128.48% -2.03%
Income Tax $130.0K $477.0K
% Of Pretax Income
Net Earnings -$23.48M -$24.72M
YoY Change -128.81% -1.06%
Net Earnings / Revenue -22.61% -22.72%
Basic Earnings Per Share -$0.65 -$0.69
Diluted Earnings Per Share -$0.65 -$0.69
COMMON SHARES
Basic Shares Outstanding 36.12M 35.82M
Diluted Shares Outstanding 36.14M 35.92M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $320.3M $329.9M
YoY Change -17.22% 6.15%
Cash & Equivalents $65.16M $65.19M
Short-Term Investments $255.1M $264.8M
Other Short-Term Assets $10.30M $11.92M
YoY Change -7.04% -1.14%
Inventory $122.4M $120.1M
Prepaid Expenses
Receivables $68.98M $69.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $522.0M $531.3M
YoY Change -7.79% 9.94%
LONG-TERM ASSETS
Property, Plant & Equipment $24.03M $34.76M
YoY Change 13.5% 67.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.863M $3.413M
YoY Change 53.75% -7.13%
Total Long-Term Assets $39.60M $38.17M
YoY Change 0.41% -6.02%
TOTAL ASSETS
Total Short-Term Assets $522.0M $531.3M
Total Long-Term Assets $39.60M $38.17M
Total Assets $561.6M $569.5M
YoY Change -7.26% 8.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.85M $30.30M
YoY Change -9.38% -3.2%
Accrued Expenses $45.30M $45.35M
YoY Change 4.41% 24.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.74M $77.53M
YoY Change -0.69% 6.69%
LONG-TERM LIABILITIES
Long-Term Debt $187.8M $187.5M
YoY Change 0.67% 0.66%
Other Long-Term Liabilities $2.265M $9.750M
YoY Change 8.06% -55.84%
Total Long-Term Liabilities $190.1M $197.2M
YoY Change 0.75% -5.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.74M $77.53M
Total Long-Term Liabilities $190.1M $197.2M
Total Liabilities $275.9M $274.8M
YoY Change -1.66% -6.52%
SHAREHOLDERS EQUITY
Retained Earnings -$690.4M -$667.0M
YoY Change 17.42% -0.38%
Common Stock $978.2M $963.6M
YoY Change 6.57% 6.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $285.7M $294.8M
YoY Change
Total Liabilities & Shareholders Equity $561.6M $569.5M
YoY Change -7.26% 8.7%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$23.48M -$24.72M
YoY Change -128.81% -1.06%
Depreciation, Depletion And Amortization $1.723M $1.671M
YoY Change 7.55% 7.05%
Cash From Operating Activities -$6.090M -$14.50M
YoY Change -107.67% 13.0%
INVESTING ACTIVITIES
Capital Expenditures $1.930M $2.208M
YoY Change -191.34% -253.87%
Acquisitions
YoY Change
Other Investing Activities $9.220M $13.48M
YoY Change -116.95% -81.2%
Cash From Investing Activities $7.280M $11.27M
YoY Change -112.88% -83.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.010M 4.122M
YoY Change -2829.73% 42.88%
NET CHANGE
Cash From Operating Activities -6.090M -14.50M
Cash From Investing Activities 7.280M 11.27M
Cash From Financing Activities -1.010M 4.122M
Net Change In Cash 180.0K 894.0K
YoY Change -99.21% -98.52%
FREE CASH FLOW
Cash From Operating Activities -$6.090M -$14.50M
Capital Expenditures $1.930M $2.208M
Free Cash Flow -$8.020M -$16.71M
YoY Change -109.84% 46.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001444380
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36715
dei Entity Registrant Name
EntityRegistrantName
Nevro Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2568057
dei Entity Address Address Line1
EntityAddressAddressLine1
1800 Bridge Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Redwood City
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94065
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
251-0005
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
NVRO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36120122
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65186000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120373000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
264756000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
254012000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
916000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1270000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69400000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78930000
CY2023Q2 us-gaap Inventory Net
InventoryNet
120088000
CY2022Q4 us-gaap Inventory Net
InventoryNet
99638000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11918000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9984000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
531348000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
562937000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23526000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22271000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11231000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13430000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2807000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3164000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
606000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
606000
CY2023Q2 us-gaap Assets
Assets
569518000
CY2022Q4 us-gaap Assets
Assets
602408000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
30298000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
26849000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41778000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47168000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5453000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5195000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
77529000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
79212000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
187489000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
186867000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7551000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10296000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2199000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2157000
CY2023Q2 us-gaap Liabilities
Liabilities
274768000
CY2022Q4 us-gaap Liabilities
Liabilities
278532000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36763038
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36203423
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36080122
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35520507
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
36000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
35000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
963521000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
934132000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1857000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3094000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-666950000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-607197000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
294750000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
323876000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
569518000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602408000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108809000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
104213000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
205136000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
192055000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34366000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31479000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66069000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
60229000
CY2023Q2 us-gaap Gross Profit
GrossProfit
74443000
CY2022Q2 us-gaap Gross Profit
GrossProfit
72734000
us-gaap Gross Profit
GrossProfit
139067000
us-gaap Gross Profit
GrossProfit
131826000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13320000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12552000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28075000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25088000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86762000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
83973000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
172954000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
163298000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
100082000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
96525000
us-gaap Operating Expenses
OperatingExpenses
201029000
us-gaap Operating Expenses
OperatingExpenses
188386000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25639000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-23791000
us-gaap Operating Income Loss
OperatingIncomeLoss
-61962000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56560000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3348000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
282000
us-gaap Investment Income Interest
InvestmentIncomeInterest
6626000
us-gaap Investment Income Interest
InvestmentIncomeInterest
425000
CY2023Q2 us-gaap Interest Expense
InterestExpense
1618000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1608000
us-gaap Interest Expense
InterestExpense
3231000
us-gaap Interest Expense
InterestExpense
3211000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-338000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
368000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-384000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
453000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24247000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24749000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58951000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58893000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
477000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
241000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
802000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
422000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-24724000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-24990000
us-gaap Net Income Loss
NetIncomeLoss
-59753000
us-gaap Net Income Loss
NetIncomeLoss
-59315000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
336000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1411000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
842000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1603000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-192000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-261000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
395000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1282000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
144000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1672000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1237000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2885000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24580000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26662000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58516000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62200000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35921539
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35921539
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35317766
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35317766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35753112
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35753112
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35196488
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35196488
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
323876000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2273000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13561000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-35029000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1093000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
301228000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1455000
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1080000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3747000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13980000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-24724000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
144000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
294750000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
303616000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
545000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7298000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13406000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-34325000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1213000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
240386000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
230000
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
759000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3414000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13376000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-24990000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1672000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
229985000
us-gaap Profit Loss
ProfitLoss
-59753000
us-gaap Profit Loss
ProfitLoss
-59315000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3212000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3056000
nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
2198000
nvro Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
2034000
us-gaap Share Based Compensation
ShareBasedCompensation
29726000
us-gaap Share Based Compensation
ShareBasedCompensation
26785000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1771000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-844000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
449000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
175000
us-gaap Inventory Write Down
InventoryWriteDown
2837000
us-gaap Inventory Write Down
InventoryWriteDown
2255000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
622000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
602000
nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
-54000
nvro Unrealized Gains And Losses On Foreign Currency Translation
UnrealizedGainsAndLossesOnForeignCurrencyTranslation
714000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9142000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2404000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22551000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1492000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1928000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6902000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-364000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-815000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3769000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1079000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7484000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8313000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2702000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2407000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43816000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41252000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
93578000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
50172000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
85000000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
173550000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4796000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3042000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13374000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
120336000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3353000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8057000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5202000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4189000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1849000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3868000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
154000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-916000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10296000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13004000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15491000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-55187000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
74300000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120979000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35316000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65792000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109616000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
435000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
664000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by the management. Actual results may differ from those estimates under different assumptions or conditions.</span></p>
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-278000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1057000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-145000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1223000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-9000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-636000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-137000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-711000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108809000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
104213000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
205136000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
192055000
CY2023Q2 nvro Bad Debt Expense1
BadDebtExpense1
300000
nvro Bad Debt Expense1
BadDebtExpense1
400000
CY2022Q2 nvro Bad Debt Expense1
BadDebtExpense1
200000
nvro Bad Debt Expense1
BadDebtExpense1
200000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M17D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3045000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6201000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2849000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
405000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
417000
CY2023Q2 nvro Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1561000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14478000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1474000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13004000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1342000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1342000
us-gaap Operating Lease Cost
OperatingLeaseCost
2685000
us-gaap Operating Lease Cost
OperatingLeaseCost
2685000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11231000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13430000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5453000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5195000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7551000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1496000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1389000
us-gaap Operating Lease Payments
OperatingLeasePayments
2974000
us-gaap Operating Lease Payments
OperatingLeasePayments
2764000
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
49800000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
92300000
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
10500000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
18600000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
265789000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1033000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
264756000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
255441000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1436000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
254012000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
241456000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
240512000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
24333000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
24244000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
265789000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
264756000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
64286000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
53384000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2419000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1195000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
53383000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
45059000
CY2023Q2 us-gaap Inventory Net
InventoryNet
120088000
CY2022Q4 us-gaap Inventory Net
InventoryNet
99638000
CY2023Q2 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
1600000
CY2022Q2 nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
1200000
nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
2800000
nvro Inventory Write Down Cash And Non Cash
InventoryWriteDownCashAndNonCash
2300000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55568000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
51102000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32042000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28831000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23526000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22271000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1671000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1561000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3212000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3056000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26865000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35341000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2936000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1425000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1878000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1910000
CY2023Q2 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
300000
CY2022Q4 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
282000
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1305000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1305000
CY2023Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1349000
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
866000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7145000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6039000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41778000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47168000
CY2021Q2 nvro Additional Operating Lease Right Of Use Asset
AdditionalOperatingLeaseRightOfUseAsset
2900000
CY2021Q2 nvro Additional Operating Lease Liability
AdditionalOperatingLeaseLiability
2900000
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
limited one- to five-year warranty
CY2023Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1147000
CY2022Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
452000
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
866000
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
664000
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1085000
CY2022Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
788000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2848000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1503000
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
883000
CY2022Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
604000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2365000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1531000
CY2023Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1349000
CY2022Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
636000
CY2023Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1349000
CY2022Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
636000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16166000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13377000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29726000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26785000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16166000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13377000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29726000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26785000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-24724000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-24990000
us-gaap Net Income Loss
NetIncomeLoss
-59753000
us-gaap Net Income Loss
NetIncomeLoss
-59315000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35921539
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35921539
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35317766
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35317766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35753112
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35753112
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35196488
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35196488
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.67
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6703366
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5922518
CY2023Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3100000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2900000

Files In Submission

Name View Source Status
0000950170-23-036543-index-headers.html Edgar Link pending
0000950170-23-036543-index.html Edgar Link pending
0000950170-23-036543.txt Edgar Link pending
0000950170-23-036543-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvro-20230630.htm Edgar Link pending
nvro-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nvro-ex10_1.htm Edgar Link pending
nvro-ex10_2.htm Edgar Link pending
nvro-ex10_3.htm Edgar Link pending
nvro-ex10_4.htm Edgar Link pending
nvro-ex10_5.htm Edgar Link pending
nvro-ex10_6.htm Edgar Link pending
nvro-ex10_7.htm Edgar Link pending
nvro-ex10_8.htm Edgar Link pending
nvro-ex10_9.htm Edgar Link pending
nvro-ex31_1.htm Edgar Link pending
nvro-ex31_2.htm Edgar Link pending
nvro-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
nvro-20230630_lab.xml Edgar Link unprocessable
nvro-20230630_pre.xml Edgar Link unprocessable
nvro-20230630_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nvro-20230630_cal.xml Edgar Link unprocessable
nvro-20230630_def.xml Edgar Link unprocessable